,Gene,Gene synonym,Ensembl,Gene description,Chromosome,Position,Protein class,Evidence,Antibody,Reliability (IH),Reliability (Mouse Brain),Reliability (IF),Subcellular location,Prognostic p-value,RNA cancer category,RNA tissue category,RNA TS,RNA TS TPM,TPM max in non-specific,RNA cell line category,RNA CS,RNA CS TPM
0,KRTAP1-5,KAP1.5,ENSG00000221852,Keratin associated protein 1-5,17,41026026-41027202,Predicted intracellular proteins,Evidence at protein level,,,,,,,Not detected,Tissue enriched,14,"cervix, uterine: 2.1",urinary bladder: 0.1,Cell line enhanced,,BJ: 23.6;BJ hTERT+: 9.7;fHDF/TERT166: 28.2;LHCN-M2: 14.9
1,IL19,"IL-10C, IL-19, MDA1, NG.1, ZMDA1",ENSG00000142224,Interleukin 19,1,206798870-206842981,"Predicted membrane proteins, Predicted secreted proteins",Evidence at protein level,,,,,,,Tissue enhanced,Tissue enriched,9,"cervix, uterine: 21.0",salivary gland: 2.3,Cell line enriched,11.0,BJ hTERT+: 4.9
2,SLPI,"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4",ENSG00000124107,Secretory leukocyte peptidase inhibitor,20,45252239-45254564,"Cancer-related genes, Plasma proteins, Predicted secreted proteins",Evidence at protein level,"CAB002303, HPA027774",Enhanced,,,,Renal cancer:6.91e-5 (unfavourable),Expressed in all,Tissue enriched,9,"cervix, uterine: 41087.8",seminal vesicle: 4333.6,Cell line enhanced,,EFO-21: 1622.9;hTCEpi: 1467.1;SiHa: 660.2
3,KRT34,"Ha-4, KRTHA4",ENSG00000131737,Keratin 34,17,41377650-41382403,"Plasma proteins, Predicted intracellular proteins",Evidence at protein level,"HPA055194, HPA072208",Supported,,Approved,Nucleus<br>Vesicles,,Tissue enhanced,Tissue enriched,8,"cervix, uterine: 4.2",testis: 0.5,Cell line enhanced,,BJ: 170.4;BJ hTERT+ SV40 Large T+ RasG12V: 45.2;HBF TERT88: 41.4
4,WFDC2,"dJ461P17.6, EDDM4, HE4, WAP5",ENSG00000101443,WAP four-disulfide core domain 2,20,45469706-45481532,"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins",Evidence at protein level,HPA042302,Enhanced,,Approved,Cytosol,"Renal cancer:4.44e-5 (favourable), Glioma:5.87e-5 (unfavourable)",Expressed in all,Tissue enriched,6,"cervix, uterine: 6567.2",seminal vesicle: 1051.7,Group enriched,8.0,A-431: 90.4;CAPAN-2: 165.0;EFO-21: 144.7;HaCaT: 121.3;RPTEC TERT1: 108.5
